Total Funding
9
Total FundingDebt Financing raised
Growth Score in past quarter
pts
Heat Score 9 in past quarter
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
INTICA Biomedical develops a combined product that consists of targeted therapy and companion diagnostics for triple negative breast cancer.
- Vicky Herrera: Founder
- Nelson Ruiz Opazo: Founder
About the Company
INTICA Biomedical, Inc. develops a combination product consisting of Targeted Therapy & Companion Diagnostic for Triple Negative Breast Cancer (TNBC). The novel drug target DEspR and its associated pathway represent true breakthrough discoveries. The NCI and the Susan G Komen Foundation are actively supporting the company's development
program in TNBC.
Women Founded
